Adagio Medical Holdings, Inc.

For the period ended Dec 31, 2025. Filed Mar 27, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 27, 2026

ADGM$1.84-4.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations and Comprehensive Loss

(in thousands, except share and per share data)


· · Years Ended December 31
· · 2025 · · 2024
· · Successor · · Successor · · · Predecessor
· · · · July 31 to December 31 · · · January 1 to July 30
Revenue	$—	$269	$333
Cost of revenue and operating expenses:
Cost of revenue	684	1,937	1,381
Research and development	10,639	4,634	7,585
Selling, general, and administrative	10,567	6,976	13,047
Impairment - Goodwill	—	30,324	—
Impairment - Intangible assets, net	—	18,878	—
Total cost of revenue and operating expenses	21,890	62,749	22,013
Loss from operations	(21,890)	(62,480)	(21,680)
Other (expense) income:
Convertible notes fair value adjustment	(980)	929	2,059
Warrant liabilities fair value adjustment	20	6,576	191
Interest expense	(2,906)	(1,105)	(1,818)
Interest income	477	420	3
Other (expense) income, net	195	1,897	(33)
Total other (loss) income, net	(3,194)	8,717	402
Net loss	$(25,084)	$(53,763)	$(21,278)
Other comprehensive loss:
Foreign currency translation adjustment	(100)	1	3
Comprehensive loss	$(25,184)	$(53,762)	$(21,275)

Basic net loss per share	$(1.51)	$(3.38)	$(26.08)
Diluted net loss per share	$(1.51)	$(3.70)	$(26.08)
Weighted-average shares outstanding – Basic	16,577,126	14,772,692	815,854
Weighted-average shares outstanding – Diluted	16,577,126	14,772,692	815,854

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.